Novartis India Limited

BSE:500672 Stock Report

Market Cap: ₹22.6b

Novartis India Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Vas Narasimhan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.9yrs
CEO ownershipn/a
Management average tenure1.7yrs
Board average tenure3.4yrs

Recent management updates

Recent updates

CEO

Vas Narasimhan (48 yo)

6.9yrs

Tenure

Dr. Vasant Narasimhan, also known as Vas, M.D., serves as Chief Executive Officer of Novartis AG at Novartis India Ltd. Dr. Narasimhan has been Chief Executive Officer of Novartis AG since February 1, 2018...

Leadership Team

NamePositionTenureCompensationOwnership
Shilpa Joshi
CFO & Whole-Time Director2.7yrsno datano data
Chandni Maru
Company Secretary & Compliance Officerless than a yearno datano data
Falin Majmudar
Whole–Time Directorless than a yearno datano data
Vasant Narasimhan
Chief Executive Officer of Novartis6.9yrsno datano data

1.7yrs

Average Tenure

55yo

Average Age

Experienced Management: 500672's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Shilpa Joshi
CFO & Whole-Time Director2.2yrsno datano data
Falin Majmudar
Whole–Time Directorless than a yearno datano data
Sanker Parameswaran
Independent Non-Executive Director4.6yrs₹1.00mno data
Christopher Snook
Non-Executive Chairman16.4yrsno datano data
Sandra Martyres
Independent Non-Executive Director8.8yrs₹1.00mno data
Gira Sardesai
Independent Directorless than a yearno datano data

3.4yrs

Average Tenure

64yo

Average Age

Experienced Board: 500672's board of directors are considered experienced (3.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 19:30
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Novartis India Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Amit GuptaBatlivala & Karani Securities India Pvt. Ltd.
Anil BurraFirstCall Research
Suhani AdilabadkarFirstCall Research